SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Kirk's Market Thoughts -- Ignore unavailable to you. Want to Upgrade?

To: Kirk © who wrote (9962)6/16/2020 11:27:11 PM
From: Investor2  Read Replies (1) | Respond to of 26764
 
The FDA referenced one study in its warning against HCQ and that study has shown to be highly suspect.



Best wishes,

I2



To: Kirk © who wrote (9962)6/17/2020 12:05:43 AM
From: Winfastorlose  Respond to of 26764
 
People are getting a first hand look at the way our system works in reality. There is no money in HCQ for the large drug companies. as a treatment for Covid-19. This has nothing to do with the efficacy or safety of HCQ/Zinc treatment.

In fact, none of their so called "studies" have included zinc as part of the protocol even though it is well established that zinc is a critical piece of the puzzle.

It is all about the money. No money no honey.

Welcome to fascism the way Mussolini intended it to be



To: Kirk © who wrote (9962)8/27/2020 9:23:52 PM
From: Investor21 Recommendation

Recommended By
Winfastorlose

  Read Replies (2) | Respond to of 26764
 


Summary is that numerous new studies indicate that HCQ when provided at normal doses does provide benefit and previous tests by WHO and other supposedly reputable organizations used doses much higher than the standard dose.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News